Table 1. Detailed demographic and clinical characteristics of EOC patients.
| Characteristics | Recurrence (N = 39) (%) | Non-recurrence (N = 31) (%) | P-value | ||
|---|---|---|---|---|---|
| ER (N = 12) | LR (N = 27) | Total | |||
| Age | |||||
| < 50 | 7(58.33) | 8(29.63) | 15(38.46) | 12(38.71) | 0.9831 |
| ≥ 50 | 5(41.67) | 19(70.37) | 24(61.54) | 19(61.29) | |
| Serum CA-125 level | |||||
| < 35 | 1(8.33) | 0(0) | 1(2.56) | 6(19.35) | 0.0240* |
| ≥ 35 | 11(91.67) | 27(100) | 38(97.44) | 25(80.65) | |
| Greater Omentum metastasis | |||||
| Absent | 3(25.00) | 5(18.52) | 8(20.51) | 19(61.29) | 0.0007* |
| Present | 8(66.67) | 20(74.07) | 28(71.79) | 11(35.48) | |
| Undocumented | 1(8.33) | 2(7.41) | 3(7.70) | 1(3.23) | |
| FIGO stage | |||||
| I | 1(8.33) | 1(3.70) | 2(5.13) | 12(38.71) | 0.0033* |
| II | 0(0) | 3(11.11) | 3(7.69) | 3(9.68) | |
| III | 10(83.34) | 22(81.48) | 32(82.05) | 16(51.61) | |
| IV | 1(8.33) | 1(3.71) | 2(5.13) | 0(0) | |
| Histology differentiation | |||||
| Well | 0(0) | 0(0) | 0(0) | 8(25.80) | 0.0015* |
| Moderately | 3(25.00) | 2(7.41) | 5(12.82) | 5(16.13) | |
| Poorly | 9(75.00) | 21(77.78) | 30(76.92) | 14(45.16) | |
| Undocumented | 0(0) | 4(14.81) | 4(10.26) | 4(12.90) | |
| Lymph node metastasis | |||||
| Absent | 7(58.33) | 18(66.67) | 25(64.10) | 29(93.55) | 0.0036* |
| Present | 5(41.67) | 9(33.33) | 14(25.90) | 2(6.55) | |
* statistically significance between recurrence in total and non-recurrence group;
Percentage in brackets is the column percent.